ATP-Dependent Translocase ABCB1 (ABCB1) Antibody

Este producto es parte de ABCB - ATP binding cassette subfamily B member
Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ATP-Dependent Translocase ABCB1 (ABCB1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx149070
tested applications
ELISA, WB, IHC, IP

Description

ATP-Dependent Translocase ABCB1 (ABCB1) Antibody is a Rabbit Polyclonal antibody for the detection of P Glycoprotein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
ATP-Dependent Translocase ABCB1 (ABCB1)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/200 - 1/1000, IHC: 1/50 - 1/500, IP: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
≥ 95% (SDS-PAGE)
Purification
Purified by immunogen affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IHC, IP
Buffer
PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P08183
Gene ID
5243
OMIM
171050
Alias
ABC20,CD243,CLCS,GP170,MDR1,P-GP,PGY1,p-170
Background
Antibody anti-ABCB1
Status
RUO
Note
Concentration: 2 mg/ml - Validity: 12 months.

Descripción

ABCB1, also known as P-glycoprotein, is a well-studied ATP-dependent efflux transporter involved in the transport of a wide range of substrates, including drugs, lipids, and xenobiotics. It is highly expressed in barrier tissues, such as the blood-brain barrier, intestines, liver, and kidneys, where it functions to protect tissues by actively exporting toxic compounds and drugs. ABCB1 plays a crucial role in pharmacokinetics, influencing drug absorption, distribution, and elimination. Overexpression of ABCB1 in cancer cells is a major contributor to multidrug resistance, as it pumps chemotherapeutic agents out of cells, reducing their efficacy. Structurally, ABCB1 contains two transmembrane domains and two ATP-binding domains, which utilize ATP hydrolysis to drive substrate transport. Its pivotal role in drug resistance and detoxification makes it a significant target in cancer therapy and pharmacological research.

Related Products

EH2377

Human ABCB1(Multidrug resistance protein 1) ELISA Kit

Ver Producto
EM0795

Mouse Abcb1(Multidrug resistance protein 1) ELISA Kit

Ver Producto
ER0678

Rat Abcb1(Multidrug resistance protein 1) ELISA Kit

Ver Producto